Clinical Trial

MammoVerse: Clinicians Focus Group

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to gather insights from clinicians who provide care to women diagnosed with breast cancer in Florida in order to identify gaps in emotional and mental health support encountered throughout the cancer care continuum. Clinicians will participate in virtual focus group discussions and complete a brief online demographic questionnaire. By capturing clinicians' perspectives on unmet psychosocial needs, barriers to support, and opportunities to improve patient-centered care, this study aims to inform the refinement of MammoVerse, an AI-based digital support platform intended to enhance emotional well-being, peer connection, and healthcare engagement among women facing breast cancer. This study offers preliminary data to inform the development of the MammoVerse AI platform later.
Trial Details
NCT Number NCT07644845
Lead Sponsor University of Central Florida
Conditions Breast Cancer
Enrollment 12 participants
Start Date 2026-02-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-12